{"sent_idx": "96", "frame_idx": "11", "ev": "The combination of ramosetron and dexamethasone could significantly reduce the incidence of moderate to severe nausea and vomiting compared to ramosetron alone.", "icos": [["1", "ramosetron and dexamethasone", "ramosetron", "moderate to severe nausea and vomiting"]], "sample": "x"}
{"sent_idx": "108", "frame_idx": "13", "ev": "Combination of ramosetron and dexamethasone significantly reduced the incidence of moderate to severe nausea and vomiting compared to ramosetron alone, although the overall incidence of PONV was similar in both groups in highly susceptible patients for PONV using fentanyl-based IV PCA following spinal surgery using volatile anesthetics.", "icos": [["1", "ramosetron and dexamethasone", "ramosetron", "moderate to severe nausea and vomiting"]], "sample": "x"}
{"sent_idx": "108", "frame_idx": "14", "ev": "Combination of ramosetron and dexamethasone significantly reduced the incidence of moderate to severe nausea and vomiting compared to ramosetron alone, although the overall incidence of PONV was similar in both groups in highly susceptible patients for PONV using fentanyl-based IV PCA following spinal surgery using volatile anesthetics.", "icos": [["1", "ramosetron and dexamethasone", "ramosetron", "incidence of PONV"]], "sample": "x"}
{"sent_idx": "81", "frame_idx": "9", "ev": "There were no side effects such as increased risk of infection and wound dehiscence associated with the use of a single dose of dexamethasone (Table 4).", "icos": [["0.9995289", "dexamethasone", "dexamethasone", "side effects"], ["0.99948174", "dexamethasone", "dexamethosone", "side effects"], ["0.99620277", "dexamethasone", "dexamethasone and 5 - HT3 antagonist", "side effects"], ["0.98151004", "dexamethasone", "Five - hydroxytryptamine receptor 3 ( 5 - HT3 ) antagonists", "side effects"], ["0.97514784", "dexamethasone", "dexamethasone to 5 -", "side effects"]], "sample": "c"}
{"sent_idx": "81", "frame_idx": "10", "ev": "There were no side effects such as increased risk of infection and wound dehiscence associated with the use of a single dose of dexamethasone (Table 4).", "icos": [["0.99945647", "dexamethasone", "dexamethasone", "risk of infection and wound dehiscence"], ["0.9991862", "dexamethasone", "dexamethosone", "risk of infection and wound dehiscence"], ["0.9977865", "dexamethasone", "dexamethasone and 5 - HT3 antagonist", "risk of infection and wound dehiscence"], ["0.9886254", "dexamethasone", "Five - hydroxytryptamine receptor 3 ( 5 - HT3 ) antagonists", "risk of infection and wound dehiscence"], ["0.98649025", "dexamethasone", "5 - HT3 antagonists", "risk of infection and wound dehiscence"]], "sample": "c"}
{"sent_idx": "0", "frame_idx": "0", "ev": "TITLE: Efficacy of dexamethasone added to ramosetron for preventing postoperative nausea and vomiting in highly susceptible patients following spine surgery", "icos": [["0.92438823", "dexamethasone", "ramosetron", "vomiting efficacy"], ["0.86055344", "dexamethasone", "ramosetron", "nausea severity"], ["0.5796615", "dexamethasone", "ramosetron", "intensity of nausea"], ["0.45351067", "dexamethasone", "ramosetron", "severity of nausea"], ["0.3846667", "dexamethasone", "ramosetron", "incidence of moderate to severe nausea"]], "sample": "o"}
